Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

1 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 1 Phase I/II: 2

Oversight events:

4 temporary halts across 1 trial

View oversight register →

Indications tested

Chronic lymphocytic leukaemia 1 Follicular lymphoma 1 Diffuse large B-cell lymphoma refractory 1 Diffuse large B-cell lymphoma recurrent 1 Diffuse large B-cell lymphoma 1 Mantle cell lymphoma 1

Sponsors using this IMP

AstraZeneca AB 4

All trials

4 total

A trial to learn how safe AZD0486 is and how well it works in older or physically weak adults with large B-cell lymphoma when given after R-… Recruiting

2025-522029-37-00 Phase III 2 countries AstraZeneca AB
A trial to learn how well surovatamig (AZD0486) works and how safe it is in adults with certain blood cancers Recruiting

2023-505789-27-00 Phase II 6 countries Astrazeneca AB
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Phase I/II 5 countries AstraZeneca AB
A trial to understand if AZD0486 is safe and helps in people with Relapsed or Refractory B-cell acute lymphoblastic leukemia (B-ALL) Halted

2023-505840-20-00 Phase I/II 4 countries Astrazeneca AB

Showing 1–4 of 4 trials

← All drugs A–Z